DE69434279D1 - Impfstoff, der einen menschlichen autologenen epidermalen Wachstumsfaktor enthält und dessen Verwendung - Google Patents

Impfstoff, der einen menschlichen autologenen epidermalen Wachstumsfaktor enthält und dessen Verwendung

Info

Publication number
DE69434279D1
DE69434279D1 DE69434279T DE69434279T DE69434279D1 DE 69434279 D1 DE69434279 D1 DE 69434279D1 DE 69434279 T DE69434279 T DE 69434279T DE 69434279 T DE69434279 T DE 69434279T DE 69434279 D1 DE69434279 D1 DE 69434279D1
Authority
DE
Germany
Prior art keywords
growth factor
epidermal growth
vaccine containing
human autologous
autologous epidermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434279T
Other languages
English (en)
Other versions
DE69434279T2 (de
Inventor
Bienvenido Lage Davila
Gisela Gonzalez Marinello
Belinda Sanchez Ramirez
Eduardo Suarez Peztana
Irene Beausoleil Delgado
Gilda Nunez Gandolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Immunologia Molecular
Original Assignee
Centro de Immunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Immunologia Molecular filed Critical Centro de Immunologia Molecular
Application granted granted Critical
Publication of DE69434279D1 publication Critical patent/DE69434279D1/de
Publication of DE69434279T2 publication Critical patent/DE69434279T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/485Epidermal growth factor [EGF], i.e. urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69434279T 1993-12-09 1994-12-08 Impfstoff, der einen menschlichen autologenen epidermalen Wachstumsfaktor enthält und dessen Verwendung Expired - Lifetime DE69434279T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU1993113 1993-12-09
CU11393 1993-12-09
CN95115090A CN1106858C (zh) 1993-12-09 1995-08-17 具有抗肿瘤活性的疫苗组合物及其在恶性疾病治疗方面的应用

Publications (2)

Publication Number Publication Date
DE69434279D1 true DE69434279D1 (de) 2005-04-07
DE69434279T2 DE69434279T2 (de) 2006-04-06

Family

ID=37708289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434279T Expired - Lifetime DE69434279T2 (de) 1993-12-09 1994-12-08 Impfstoff, der einen menschlichen autologenen epidermalen Wachstumsfaktor enthält und dessen Verwendung

Country Status (6)

Country Link
EP (1) EP0657175B1 (de)
JP (1) JP2823519B2 (de)
CN (1) CN1106858C (de)
CA (1) CA2137639C (de)
DE (1) DE69434279T2 (de)
ES (1) ES2237750T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000053219A2 (en) * 1999-03-11 2000-09-14 Entremed, Inc. Compositions and methods for treating cancer and hyperproliferative disorders
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
CU22979A1 (es) * 2000-12-08 2004-09-09 Centro Inmunologia Molecular Combinación inmunoterapéutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina
US8399440B2 (en) 2006-03-20 2013-03-19 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol
CU23652A1 (es) 2007-06-29 2011-05-27 Centro Inmunologia Molecular Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención
CN102078604A (zh) * 2010-12-31 2011-06-01 北京民海生物科技有限公司 脑膜炎球菌荚膜多糖多价结合疫苗,其制备方法和应用
LT2782598T (lt) * 2011-11-23 2020-07-27 In3Bio Ltd. Rekombinantiniai baltymai ir jų terapinis panaudojimas
RU2747857C2 (ru) 2013-03-15 2021-05-17 Ин3Био Лтд. Самособирающиеся синтетические белки
WO2018009916A1 (en) * 2016-07-07 2018-01-11 The Board Of Trustees Of The Leland Stanford Junior University Antibody adjuvant conjugates
CU20170173A7 (es) * 2017-12-27 2019-11-04 Ct Inmunologia Molecular Nano-partículas que contienen el gangliósido gm3 como inmunomoduladoras

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN165717B (de) * 1986-08-07 1989-12-23 Battelle Memorial Institute
JPH04506662A (ja) * 1989-07-14 1992-11-19 アメリカン・サイアナミド・カンパニー 接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー
WO1991009871A1 (en) * 1989-12-22 1991-07-11 Seragen Incorporated Hybrid molecules having translocation region and cell-binding region

Also Published As

Publication number Publication date
CN1106858C (zh) 2003-04-30
JP2823519B2 (ja) 1998-11-11
EP0657175A3 (de) 1996-12-18
DE69434279T2 (de) 2006-04-06
EP0657175A2 (de) 1995-06-14
CA2137639A1 (en) 1995-06-10
CA2137639C (en) 1999-01-26
ES2237750T3 (es) 2005-08-01
JPH07285883A (ja) 1995-10-31
CN1142973A (zh) 1997-02-19
EP0657175B1 (de) 2005-03-02

Similar Documents

Publication Publication Date Title
ATA189691A (de) Hpth-peptide, ihre herstellung und verwendung
DE69229724D1 (de) Hochabsorbierende materialien sowie verwendung derselben
DE68907987T2 (de) Filter und Dosierungsfläschchen sowie dessen Verwendung.
DE69233474D1 (de) Pharmazeutische Zusammensetzung enthaltend S-Nitrosoimmunoglobuline und Verwendung davon
DE69719603D1 (de) Kosmetisches Haarwaschmittel und dessen Verwendung
DK561789A (da) Parasolstel
DE69600048T2 (de) Kosmetisches Haarwaschmittel und dessen Verwendung
ATE243708T1 (de) Substituierte imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE68910113T2 (de) Wachstuminhibierendes mittel und dessen verwendung.
DE69620270D1 (de) Backfett und dessen Verwendung
TR26513A (tr) Yeni ikame edilmis pirazolilpirazoller hazirlanma- larina mahsus islemler ara maddeleri ve herbisid olarak kullanilmalari
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69406662D1 (de) Einsätze zur verwendung bei der gewebekultur
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
ATE449786T1 (de) Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
HU913137D0 (en) 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use
DE69434279D1 (de) Impfstoff, der einen menschlichen autologenen epidermalen Wachstumsfaktor enthält und dessen Verwendung
DE69534371D1 (de) Wachstumsfaktoren enthaldende therapeutische homöopathische verdünnungen und verwendung
DE69118615T2 (de) Organisches lichtemittierendes Bauelement sowie dessen Herstellung und Verwendung
DE68906198T2 (de) Lichterregbarer leuchtstoff und dessen verwendung in der radiographie.
NO307868B1 (no) Ballong for kunstig Õndedrett
DE3887417T2 (de) Thienocinnolinverbindungen und deren verwendung als heilmittel.
DE69330114D1 (de) Methandiphosphonat-derivat, dessen produktion und dessen verwendung als arzneimittel
DE69009204T2 (de) Hydroxyperoxide und ihre Verwendung.
DE59207083D1 (de) Pyroelektrisches Keramikmaterial und dessen Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition